Pharmabiz

CollPlant announces positive results from non-clinical studies of its photocurable regenerative dermal and soft tissue filler

CollPlant announces positive results from non-clinical studies of its photocurable regenerative dermal and soft tissue filler: Rehovot, Israel Wednesday, October 1, 2025, 18:00 Hr ...
Pharmabiz

Hinduja Hospital launches ‘Unmute Your Heart 2.0’ campaign to urge Mumbaikars to tackle the hidden congestion in their hearts

Hinduja Hospital launches ‘Unmute Your Heart 2.0’ campaign to urge Mumbaikars to tackle the hidden congestion in their hearts ...
Pharmabiz

Japan’s MHLW grants orphan drug designation to Vicore Pharma’s buloxibutid to treat idiopathic pulmonary fibrosis

Japan’s MHLW grants orphan drug designation to Vicore Pharma’s buloxibutid to treat idiopathic pulmonary fibrosis: Stockholm Wednesday, October 1, 2025, 17:00 Hrs [IST] Vicore ...
Pharmabiz

Data show Roche’s sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks

Data show Roche’s sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks: Basel Wednesday, October 1, 2025, 11:00 Hrs [IST] Roche ...
Pharmabiz

Lupin receives US FDA approval for rivaroxaban for oral suspension

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for rivaroxaban for ...
Pharmabiz

Data4Life and EvidNet form strategic partnership to advance federated real-world evidence generation

Data4Life and EvidNet form strategic partnership to advance federated real-world evidence generation: Seoul, South Korea Wednesday, October 1, 2025, 13:00 Hrs [IST] Nonprofit digi ...
Pharmabiz

Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility

Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility: Dublin Wednesday, October 1, 2025, 16:00 Hrs [IST] Cardinal Health, a distributor of ...
Pharmabiz

Symbiosis expands sterile manufacturing capacity with fill/finish line qualification

Symbiosis expands sterile manufacturing capacity with fill/finish line qualification: Stirling, UK Wednesday, October 1, 2025, 14:00 Hrs [IST] Symbiosis Pharmaceutical Services (S ...
Pharmabiz

Novartis to launch direct-to-patient platform for Cosentyx in the US

Novartis to launch direct-to-patient platform for Cosentyx in the US: Basel Wednesday, October 1, 2025, 12:00 Hrs [IST] Novartis announced plans to launch a direct-to-patient (DTP ...
Pharmabiz

Pfizer reaches landmark agreement with US government to lower drug costs for American patients

Pfizer reaches landmark agreement with US government to lower drug costs for American patients: New York Wednesday, October 1, 2025, 16:30 Hrs [IST] Pfizer Inc. announced a histor ...
Pharmabiz

Kedrion Biopharma receives US FDA approval for Qivigy to treat adults with primary humoral immunodeficiency

Kedrion Biopharma receives US FDA approval for Qivigy to treat adults with primary humoral immunodeficiency: Barga, Italy Wednesday, October 1, 2025, 10:00 Hrs [IST] Kedrion Bioph ...
Pharmabiz

Epigenica AB launches the groundbreaking EpiFinder GenomePro

Epigenica AB, the leader in epigenomic innovation, announces the launch of the EpiFinder GenomePro, a cutting-edge platform for advanced epigenomic research. The EpiFinder GenomePro enables ...